Altimmune, Inc. (ALT) market cap

Market cap today
$297.72M

Altimmune, Inc. (ALT) has a market cap of $297.72M. At the end of fiscal 2025 (December 31, 2025) its market cap was $318.06M. That is 37.9% lower than the $511.93M of fiscal 2024. Today's figure is 6.4% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 05:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$297.72M
Market cap, fiscal 2025
$318.06M
Change on fiscal 2024
−37.9%
Growth, 5 years
+1.9% a year
Highest on record
$771.94Mfiscal 2022
Lowest on record
$289.19Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Altimmune, Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 1.9% a year. Across the 6 fiscal year-ends on record (2020–2025), the highest was $771.94M in fiscal 2022 and the lowest $289.19M in fiscal 2020.

History · 6 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Altimmune, Inc. market cap, year by year

Altimmune, Inc. (ALT) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$297.72M—$1.53—
2025$318.06M 37.9% down$3.6188.10M
2024$511.93M 14.5% down$7.2171.00M
2023$599.03M 22.4% down$11.2553.25M
2022$771.94M 104.1% up$16.4546.93M
2021$378.16M 30.8% up$9.1641.28M
2020$289.19M—$11.2825.64M
2019——$1.89—
2018——$2.06—
2017——$59.70—
2016———2.19M
2015———2.13M
2014———1.92M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on ALT

Altimmune, Inc., figure by figure

Altimmune, Inc. (ALT) overview: price, valuation and scorecard

Altimmune, Inc. market cap: questions and answers

What is Altimmune, Inc.'s market cap?

Altimmune, Inc. (ALT) has a market cap of $297.72M. At the end of fiscal 2025 (December 31, 2025) its market cap was $318.06M. That is 37.9% lower than the $511.93M of fiscal 2024.

What is the growth rate of Altimmune, Inc.'s market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 1.9% a year.

What are the highest and lowest market cap figures on record for Altimmune, Inc.?

Across the 6 fiscal year-ends on record (2020–2025), the highest was $771.94M in fiscal 2022 and the lowest $289.19M in fiscal 2020.

How is Altimmune, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Altimmune, Inc. (ALT) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/ALT/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.